ImmuPharma (LON:IMM) Trading 168.7% Higher – Here’s What Happened

ImmuPharma plc (LON:IMM – Get Free Report) shares traded up 168.7% during mid-day trading on Thursday . The company traded as high as GBX 3.80 ($0.05) and last traded at GBX 3.22 ($0.04). 61,345,711 shares were traded during mid-day trading, an increase of 451% from the average session volume of 11,133,673 shares. The stock had previously closed at GBX 1.20 ($0.01).

ImmuPharma Price Performance

The company has a market capitalization of £15.30 million, a P/E ratio of -367.30 and a beta of 1.53. The firm’s 50-day moving average is GBX 1.40 and its 200-day moving average is GBX 1.65.

ImmuPharma Company Profile

(Get Free Report)

ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.

Featured Stories

• Five stocks we like better than ImmuPharma
• What Makes a Stock a Good Dividend Stock?
• Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
• The 3 Best Blue-Chip Stocks to Buy Now
• Why Amazon’s Next Earnings Could Trigger a Stock Breakout
• Bank Stocks – Best Bank Stocks to Invest In
• With This Kind of Data, The Fed Isn’t Cutting Rates This Year